Pulmotrop Axacap

Aperçu du produit

About Pulmotrop Axacap

Pulmotrop Axacap is a medication containing the active ingredient Tiotropium. 1 INDICATIONS AND USAGE STIOLTO RESPIMAT is a combination of tiotropium bromide, an anticholinergic and olodaterol, a long-acting beta 2 -adrenergic agonist (LABA) indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE STIOLTO RESPIMAT is a combination of tiotropium bromide, an anticholinergic and olodaterol, a long-acting beta 2 -adrenergic.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Tiotropium, the active ingredient in Pulmotrop Axacap, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE STIOLTO RESPIMAT is a combination of tiotropium bromide, an anticholinergic and olodaterol, a long-acting beta 2 -adrenergic agonist (LABA) indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Pulmotrop Axacap. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Pulmotrop Axacap for extended periods without medical advice.